Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-29
2005-03-29
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06872738
ABSTRACT:
The invention concerns a product comprising at least a NO synthase inhibiting substance associated with at least a phospholipase A2 inhibiting substance, separately or combined, for simultaneous therapeutic use, separately or spread over time for treating pathologies in which nitrogen monoxide and/or phospholipases A2 are involved. The invention also concerns a pharmaceutical composition comprising, an active principle, at least a NO synthase inhibiting substance and at least a phospholipase A2 inhibiting substance, and optionally a pharmaceutically acceptable.
REFERENCES:
patent: 6335445 (2002-01-01), Chabrier de Lassauniere et al.
Holscher et al, “Inhibitors of . . . Spatial Task”, Neuroreport (1995) vol. 6, No. 5, pp. 730-732, XP000923049.
Nishibori et al, “Effect of . . . Parotid Gland”, Adv. Biosci. (1982), 33(Adv. Histamine Res.), pp. 203-209, XP000923046.
Auguet Michel
Chabrier de Lassauniere Pierre-Etienne
Muserlian Lucas and Mercanti
Powers Fiona T.
Societe de Conseils de Recherches et D'Applications Scientifique
LandOfFree
Product comprising at least a no synthase inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Product comprising at least a no synthase inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Product comprising at least a no synthase inhibiting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3441956